(Total Views: 394)
Posted On: 02/24/2021 6:08:30 PM
Post# of 155757

Re: Borel Fields #79748
From bamlanivimab's phase 3 trial -
Quote:
Ongoing, but accrual of patients receiving bamlanivimab stopped due to lack of benefit

